Diagnosis of Alzheimer's disease is often missed or delayed in clinical practice; thus, methods to improve early detection would provide opportunities for early intervention, symptomatic treatment, and improved patient function. Emerging data suggest that the disease process begins years before clinical diagnostic confirmation. This paper reviews current research focusing on methods for more specific and sensitive early detection using measures of genetic risk for Alzheimer's disease and functional brain imaging. This approach aims to identify patients in a presymptomatic stage for early treatment to delay progressive cognitive decline and disease onset
Neuroimaging biomarkers have potential role in the early diagnosis as well as periodic follow-up of ...
Recently published guidelines suggest that the most opportune time to treat individuals with Alzheim...
Early and accurate diagnosis of Alzheimer’s disease, which is the most common cause of dementia, is ...
Diagnosis of Alzheimer's disease is often missed or delayed in clinical practice; thus, methods to i...
International audienceINTRODUCTION: Diagnosis of Alzheimer's disease (AD) remains difficult to estab...
Alzheimer’s disease (AD) starts at a molecular level possibly decades earlier than could be detected...
Alzheimer’s disease is a progressive, irreversible neurodegenerative disease impacting cognition, fu...
Numerous studies show that the pathology of Alzheimer’s disease is present decades before a clinical...
Alzheimer's disease (AD) is the most common neurodegenerative disease among the elderly with a progr...
Early diagnosis of Alzheimer's disease (with the announcement of the diagnosis). The number of patie...
Due to the aging population, within the next 20-30years the number of individuals with dementia, mos...
Current state-of-the-art diagnostic measures of Alzheimer's disease (AD) are invasive (cerebrospinal...
The recent proposed criteria for Alzheimer's Disease (AD) have strongly claimed the usefulness of bi...
Alzheimer's disease is a progressive neurodegenerative disease that typically manifests clinically a...
Alzheimer disease (AD) represents the most common neurodegenerative disease worldwide, accounting fo...
Neuroimaging biomarkers have potential role in the early diagnosis as well as periodic follow-up of ...
Recently published guidelines suggest that the most opportune time to treat individuals with Alzheim...
Early and accurate diagnosis of Alzheimer’s disease, which is the most common cause of dementia, is ...
Diagnosis of Alzheimer's disease is often missed or delayed in clinical practice; thus, methods to i...
International audienceINTRODUCTION: Diagnosis of Alzheimer's disease (AD) remains difficult to estab...
Alzheimer’s disease (AD) starts at a molecular level possibly decades earlier than could be detected...
Alzheimer’s disease is a progressive, irreversible neurodegenerative disease impacting cognition, fu...
Numerous studies show that the pathology of Alzheimer’s disease is present decades before a clinical...
Alzheimer's disease (AD) is the most common neurodegenerative disease among the elderly with a progr...
Early diagnosis of Alzheimer's disease (with the announcement of the diagnosis). The number of patie...
Due to the aging population, within the next 20-30years the number of individuals with dementia, mos...
Current state-of-the-art diagnostic measures of Alzheimer's disease (AD) are invasive (cerebrospinal...
The recent proposed criteria for Alzheimer's Disease (AD) have strongly claimed the usefulness of bi...
Alzheimer's disease is a progressive neurodegenerative disease that typically manifests clinically a...
Alzheimer disease (AD) represents the most common neurodegenerative disease worldwide, accounting fo...
Neuroimaging biomarkers have potential role in the early diagnosis as well as periodic follow-up of ...
Recently published guidelines suggest that the most opportune time to treat individuals with Alzheim...
Early and accurate diagnosis of Alzheimer’s disease, which is the most common cause of dementia, is ...